India’s E-pharmacy segment mints its first unicorn, raises $350 million

India’s E-pharmacy segment mints its first unicorn, raises $350 million

25
0
SHARE


API Holdings Pvt., one of India’s largest digital pharmacies, announced on Wednesday that it has raised $350 million from Prosus Ventures and TPG Growth LLC. The company was valued at close to $1.5 billion, according to a person familiar with the deal, adding to a rapidly growing list of unicorn startups in the country.

The firm is already raising its next round at a valuation of about $1.8 billion, the person said, wishing to remain anonymous as the fresh round is still underway.

The Mumbai-headquartered company said it will use the funds to expand its pharmacy network and add more tele-consultations to link up customers with the 60,000 brick-and-mortar pharmacies and 4,000 doctors it already has on its books. Existing investors including Temasek Holdings Pte and CDPQ participated in the Series E round.

India’s drug distribution system is disorganized, lacking established retail chains and forcing neighborhood pharmacies to depend on thousands of middlemen as a go-between with drugmakers. Large players like Reliance Industries, which recently acquired startup Netmeds, and Tata Group, which is poised to buy competitor 1MG, are making moves to enter and organize the market. Amazon.com Inc. began supplying medicines last summer. API provides supply chain support to pharmacies while also helping them access customers locally.

“Availability of medicines, genuineness and affordability are all wanting in the existing physical infrastructure,” said Siddharth Shah, the stathertup’s co-founder and chief executive officer, in a video conference call to discuss the “Rather than create everything new, we are overlaying a digital solution on top of the existing brick & mortar stores so it’s a lot more efficient.”

He declined to disclose the valuation.

Shah, now 32, graduated from the prestigious Indian Institute of Management in Ahmedabad before dropping out halfway through an internship at Goldman Sachs Group Inc. The Goldman experience helped him realize he wasn’t cut out for a regular job, said Shah, who turned to entrepreneurship nine years ago.

India’s archaic pharma supply chain with over 1,000 manufacturers, 55,000 distributors and sub-distributors and more than 800,000 pharmacy outlets, is ripe for disruption.

API, operating under the consumer brand PharmEasy, helps digitize and organize drug supply chains to provide timely access to medicines. It also helps with procurement, delivery and logistics, and provides credit to retailers. It currently supplies 200,000 products from over 3,000 drugmakers. With the latest round of funding, the startup is targeting over 100,000 pharmacies in 100 cities in the next 12 months and over 20 million patients annually.

“It’s a huge space and startups have a chance to disrupt current inefficiencies,” said Ashutosh Sharma, head of India investments at Prosus Ventures, on the same call. “Only local founders can build for the next 500 million customers, it can’t be a Western approach.”

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor



Source link

LEAVE A REPLY